ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Heavy Smokers More Resistant To Quitting,

March 10, 1995

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

Committee Approves Concepts For Studies In Special Populations

December 11, 1987